Literature DB >> 19706866

Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?

Deepak L Bhatt.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19706866     DOI: 10.1001/jama.2009.1249

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  Emerging clinical applications in cardiovascular pharmacogenomics.

Authors:  Samir B Damani; Eric J Topol
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-08-20

Review 2.  The evolution of antiplatelet therapy in cardiovascular disease.

Authors:  Omair Yousuf; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2011-07-12       Impact factor: 32.419

3.  Antiplatelet therapy: Ticagrelor in ACS-what does PLATO teach us?

Authors:  Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2009-12       Impact factor: 32.419

4.  Clopidogrel resistance - a clear problem with an unclear solution.

Authors:  Sameer Bansilal; Deepak L Bhatt
Journal:  Indian Heart J       Date:  2012-06-21

Review 5.  The pharmacogenetics of antiplatelet agents: towards personalized therapy?

Authors:  Tariq Ahmad; Deepak Voora; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

Review 6.  Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

Authors:  Joseph P Kitzmiller; David K Groen; Mitch A Phelps; Wolfgang Sadee
Journal:  Cleve Clin J Med       Date:  2011-04       Impact factor: 2.321

Review 7.  Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.

Authors:  Kumaran Kolandaivelu; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2010-06-01       Impact factor: 32.419

Review 8.  Is the use of sentient animals in basic research justifiable?

Authors:  Ray Greek; Jean Greek
Journal:  Philos Ethics Humanit Med       Date:  2010-09-08       Impact factor: 2.464

9.  The neuro-critical care management of the endovascular stroke patient.

Authors:  Vishal N Patel; Rishi Gupta; Christopher M Horn; Tommy T Thomas; Raul G Nogueira
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

10.  A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes.

Authors:  Ran Xiong; Wenxian Liu; Liying Chen; Tieduo Kang; Shangqiu Ning; Jiang Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.